| In millions, except per share items | Jan-02-16 | Jan-03-15 | Dec-28-13 | Dec-29-12 |
| | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Symmetry Surgical branded | 76.9 | 72.4 | | 86.5 |
| Alliance Partners | 7.6 | 9.4 | | 20.5 |
| Total revenues | 84.5 | 81.8 | 88.9 | 107.0 |
| Revenue growth [+] | 3.4% | -8.1% | -16.9% | |
| Symmetry Surgical branded | 6.3% | | | |
| Alliance Partners | -19.4% | | | |
| Cost of goods sold | 45.1 | 46.1 | 48.4 | 55.2 |
| Gross profit | 39.5 | 35.7 | 40.6 | 51.8 |
| Gross margin | 46.7% | 43.6% | 45.6% | 48.4% |
| Selling, general and administrative [+] | 36.5 | 36.0 | 38.8 | 37.3 |
| Sales and marketing | 16.9 | 17.4 | 18.3 | 19.1 |
| General and administrative | 19.5 | 18.6 | 20.5 | 18.2 |
| Other operating expenses | | | | -6.6 |
| EBITDA [+] | 9.5 | 6.0 | 7.9 | 21.1 |
| EBITDA growth | 58.6% | -24.1% | -62.7% | |
| EBITDA margin | 11.2% | 7.3% | 8.8% | 19.7% |
| Depreciation | 0.9 | 1.0 | 1.1 | 0.8 |
| EBITA | 8.5 | 5.0 | 6.8 | 20.3 |
| EBITA margin | 10.1% | 6.1% | 7.6% | 19.0% |
| Amortization of intangibles | 5.6 | 5.4 | 5.0 | 5.8 |
| EBIT [+] | 3.0 | -0.4 | 1.8 | 14.5 |
| EBIT growth | -926.6% | -120.5% | -87.9% | |
| EBIT margin | 3.5% | -0.4% | 2.0% | 13.6% |
| Non-recurring items [+] | 1.0 | 55.8 | 20.1 | |
| Asset impairment | 1.0 | 55.8 | 20.1 | 20.1 |
| Interest expense | 0.2 | 0.0 | | |
| Interest expense | 0.2 | 0.0 | | |
| Other income (expense), net | -0.3 | -0.2 | -0.3 | 0.2 |
| Pre-tax income | 1.5 | -56.4 | -18.6 | 14.8 |
| Income taxes | 0.3 | -20.7 | -6.4 | 5.6 |
| Tax rate | 18.9% | 36.6% | 34.6% | 38.2% |
| Net income | 1.2 | -35.8 | -12.2 | 9.1 |
| Net margin | 1.4% | -43.7% | -13.7% | 8.5% |
| |
| Basic EPS [+] | $0.12 | ($3.73) | ($1.27) | $0.95 |
| Growth | -103.3% | 193.6% | -233.6% | |
| Diluted EPS [+] | $0.12 | ($3.73) | ($1.27) | $0.95 |
| Growth | -103.3% | 193.6% | -233.6% | |
| |
| Shares outstanding (basic) [+] | 9.6 | 9.6 | 9.6 | 9.6 |
| Growth | 0.6% | 0.0% | 0.0% | |
| Shares outstanding (diluted) [+] | 9.7 | 9.6 | 9.6 | 9.6 |
| Growth | 1.1% | 0.0% | 0.0% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |